Ir al menú de navegación principal Ir al contenido principal Ir al pie de página del sitio

A mini review of studies that include the therapeutic role of Chloroquine and Hydroxychloroquine in coronavirus disease-19 (COVID-19)

A mini review of studies that include the therapeutic role of Chloroquine and Hydroxychloroquine in coronavirus disease-19 (COVID-19) Una mini revisión de estudios que incluyen el papel terapéutico de la cloroquina y la hidroxicloroquina en la enfermedad por coronavirus-19 (COVID-19)




Sección
Artículos de COVID 19

Cómo citar
Al msaoudi, G., Sako, J., Alzahrani, M. ., & Al-Hindi, Y. (2021). A mini review of studies that include the therapeutic role of Chloroquine and Hydroxychloroquine in coronavirus disease-19 (COVID-19): Una mini revisión de estudios que incluyen el papel terapéutico de la cloroquina y la hidroxicloroquina en la enfermedad por coronavirus-19 (COVID-19). Archivos De Medicina, 21(1), 279-284. https://doi.org/10.30554/archmed.21.1.4008.2021
Descargar cita

Dimensions
PlumX

Cómo citar

Al msaoudi, G., Sako, J., Alzahrani, M. ., & Al-Hindi, Y. (2021). A mini review of studies that include the therapeutic role of Chloroquine and Hydroxychloroquine in coronavirus disease-19 (COVID-19): Una mini revisión de estudios que incluyen el papel terapéutico de la cloroquina y la hidroxicloroquina en la enfermedad por coronavirus-19 (COVID-19). Archivos De Medicina, 21(1), 279-284. https://doi.org/10.30554/archmed.21.1.4008.2021

Descargar cita

Licencia
Creative Commons License

Esta obra está bajo una licencia internacional Creative Commons Atribución-NoComercial-SinDerivadas 4.0.

Ghdi Al msaoudi
Jumana Sako
Maha Alzahrani
Yosra Al-Hindi

Ghdi Al msaoudi,

Pharm D candidate, Faculty of pharmacy, Umm Al-Qura University, Makkah, Saudi Arabia. 


Jumana Sako,

Pharm D candidate, Faculty of pharmacy, Umm Al-Qura University, Makkah, Saudi Arabia. 


Maha Alzahrani,

Pharm D candidate, Faculty of pharmacy, Ibn-Sina National College, Jeddah, Saudi Arabia. 
 


Yosra Al-Hindi,

Assistant Professor, Faculty of pharmacy, Umm Al-Qura University, Makkah, Saudi Arabia. 


COVID-19 (Coronavirus Disease-2019) is now considered a public health
emergency of that concerns the whole globe. Despite it is still not approved, the use of aminoquinoline drugs such as chloroquine and hydroxychloroquine are now in increasing, especially with the pandemic of coronavirus disease 2019 (COVID-19). This mini review highlights the main information's gathered of using the therapeutic purpose of both these medications in the extraordinary situation of coronavirus disease -19.


Visitas del artículo 599 | Visitas PDF 75


Descargas

Los datos de descarga todavía no están disponibles.
  1. Cortegiani A, Ingoglia G, Ippolito M, Giarratano A, Einav S. A systematic review on the efficacy and safety of chloroquine for the treatment of COVID-19. J Crit Care. 2020; 57:279-283. https://doi.org/10.1016/j.jcrc.2020.03.005
  2. Borba MG, Val FF, Sampaio VS, Alexandre MA, Melo GC, Brito M, et al. Effect of high vs low doses of chloroquine diphosphate as adjunctive therapy for patients hospitalized with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection: a randomized clinical trial. JAMA network open. 2020; 3(4):1-14.DOI: 10.1001/jamanetworkopen.2020.8857
  3. Tang D, Li J, Zhang R, Kang R, Klionsky DJ. Chloroquine in fighting COVID-19: good, bad, or both?. Autophagy. 2020; 25:1-3. https://doi.org/10.1080/15548627.2020.1796014
  4. Singh AK, Singh A, Singh R, Misra A. Hydroxychloroquine in patients with COVID-19: A Systematic Review and meta-analysis. Diabetes Metab Syndr. 2020; 14(4):589-596. https://doi.org/10.1016/j.dsx.2020.05.017
  5. Bishara D, Kalafatis C, Taylor D. Emerging and experimental treatments for COVID-19 and drug interactions with psychotropic agents. Ther Adv Psychopharmacol. 2020;10:1-15. DOI: 10.1177/ 2045125320935306
  6. Colson P, Rolain JM, Raoult D. Chloroquine for the 2019 novel coronavirus SARS-CoV-2. Int J Antimicrob Agents. 2020; 55(3):1-2. https://doi.org/10.1016/j.ijantimicag.2020.105923
  7. Das S, Bhowmick S, Tiwari S, Sen S. An Updated Systematic Review of the Therapeutic Role of Hydroxychloroquine in Coronavirus Disease-19 (COVID-19). Clin Drug Investig. 2020; 1-11. https://doi.org/10.1007/s40261-020-00927-1
  8. Jankelson L, Karam G, Becker ML, Chinitz LA, Tsai MC. QT prolongation, torsades de pointes and sudden death with short courses of chloroquine or hydroxychloroquine as used in COVID-19: a systematic review. Heart Rhythm. 2020; 17(9):1472-1479.
  9. https://doi.org/10.1016/j.hrthm.2020.05.008
  10. Patil VM, Singhal S, Masand N. A systematic review on use of aminoquinolines for the therapeutic management of COVID-19: Efficacy, safety and clinical trials. Life Sciences. 2020;117775. https://doi.org/10.1016/j.lfs.2020.117775
  11. Prayuenyong, P, Kasbekar, AV, Baguley, DM. Clinical Implications of Chloroquine and Hydroxychloroquine Ototoxicity for COVID-19 Treatment: A Mini-Review. Front Public Health. 2020; 8:1-6. DOI:10.3389/fpubh.2020.00252
  12. Sarma P, Kaur H, Kumar H, Mahendru D, Avti P, Bhattacharyya A,et al. Virological and clinical cure in COVID 19 patients treated with hydroxychloroquine: a systematic review and meta-analysis. J Med Virol. 2020;92(7):776–785. DOI: 10.1002/jmv.25898
  13. Shah S, Das S, Jain A, Misra DP, Negi VS. A systematic review of the prophylactic role of chloroquine and hydroxychloroquine in coronavirus disease 19 (COVID19). Int J Rheum Dis. 2020; 23(5):613-619. DOI: 10.1111/1756-185X.13842
  14. Ji LN, Chao S, Wang YJ, Li XJ, Mu XD, Lin MG, et al. Clinical features of pediatric patients with COVID-19: a report of two-family cluster cases. World Journal of Pediatrics. 2020;16:267–270. https://doi.org/10.1007/s12519-020-00356-2
  15. Tripathy S, Dassarma B, Roy S, Chabalala H, Matsabisa MG. A review on possible modes of actions of Chloroquine/Hydroxychloroquine: Repurposing against SAR-COV-2 (COVID 19) pandemic. Int J Antimicrob Agents. 2020; 56(2):1-7. https://doi.org/10.1016/j.ijantimicag.2020.106028
Sistema OJS 3.4.0.10 - Metabiblioteca |